Cargando…

The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment

BACKGROUND: Metabolic modulation is capable of maintaining cell potency, regulating niche homeostasis, or determining cell fate. However, little is known regarding the metabolic landscape during early adipogenesis or whether metabolic modulation could be a potential approach for obesity treatment. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Weilong, Chen, Qiang, Wang, Haitao, Qiu, Pengxiang, Lyu, Xueying, Chen, Weiping, Chua, Melvin L.K., Chinn, Y. Eugene, Deng, Chu-Xia, Wang, Ruihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940659/
https://www.ncbi.nlm.nih.gov/pubmed/31901865
http://dx.doi.org/10.1016/j.ebiom.2019.102605
_version_ 1783484379566178304
author Hou, Weilong
Chen, Qiang
Wang, Haitao
Qiu, Pengxiang
Lyu, Xueying
Chen, Weiping
Chua, Melvin L.K.
Chinn, Y. Eugene
Deng, Chu-Xia
Wang, Ruihong
author_facet Hou, Weilong
Chen, Qiang
Wang, Haitao
Qiu, Pengxiang
Lyu, Xueying
Chen, Weiping
Chua, Melvin L.K.
Chinn, Y. Eugene
Deng, Chu-Xia
Wang, Ruihong
author_sort Hou, Weilong
collection PubMed
description BACKGROUND: Metabolic modulation is capable of maintaining cell potency, regulating niche homeostasis, or determining cell fate. However, little is known regarding the metabolic landscape during early adipogenesis or whether metabolic modulation could be a potential approach for obesity treatment. METHODS: The metabolic footprint during adipocyte commitment was evaluated by metabolomics analysis in mouse embryonic fibroblasts (MEFs). The role of apoptosis induced by ceramide and how ceramide is regulated were evaluated by omics analysis in vitro, human database and the adipocyte-specific Sirt1 knockout mouse. FINDINGS: The metabolic footprint showed that a complicated diversity of metabolism was enriched as early as 3 h and tended to fluctuate throughout differentiation. Subsequently, the scale of these perturbed metabolic patterns was reduced to reach a balanced state. Of high relevance is the presence of apoptosis induced by ceramide accumulation, which is associated with metabolic dynamics. Interestingly, apoptotic cells were not merely a byproduct of adipogenesis but rather promoted the release of lipid components to facilitate adipogenesis. Mechanistically, ceramide accumulation stemming from hydrolysis and the de novo pathway during early adipogenesis is regulated by Sirt1 upon epigenetic alterations of constitutive Histone H3K4 methylation and H3K9 acetylation. INTERPRETATION: The metabolic footprint during adipocyte commitment highlights that apoptosis induced by ceramide is essential for adipogenesis, which is reversed by suppression of Sirt1. Therefore, Sirt1 may constitute a target to treat obesity or other ceramide-associated metabolic syndromes. FUNDING: This project was supported by grants from the University of Macau (SRG2015-00008-FHS, MYRG2016-00054-FHS and MYRG2017-00096-FHS to RHW; CPG2019-00019-FHS to CXD) and from the National Natural Science Foundation of China (81672603 and 81401978) to QC.
format Online
Article
Text
id pubmed-6940659
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69406592020-01-06 The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment Hou, Weilong Chen, Qiang Wang, Haitao Qiu, Pengxiang Lyu, Xueying Chen, Weiping Chua, Melvin L.K. Chinn, Y. Eugene Deng, Chu-Xia Wang, Ruihong EBioMedicine Research paper BACKGROUND: Metabolic modulation is capable of maintaining cell potency, regulating niche homeostasis, or determining cell fate. However, little is known regarding the metabolic landscape during early adipogenesis or whether metabolic modulation could be a potential approach for obesity treatment. METHODS: The metabolic footprint during adipocyte commitment was evaluated by metabolomics analysis in mouse embryonic fibroblasts (MEFs). The role of apoptosis induced by ceramide and how ceramide is regulated were evaluated by omics analysis in vitro, human database and the adipocyte-specific Sirt1 knockout mouse. FINDINGS: The metabolic footprint showed that a complicated diversity of metabolism was enriched as early as 3 h and tended to fluctuate throughout differentiation. Subsequently, the scale of these perturbed metabolic patterns was reduced to reach a balanced state. Of high relevance is the presence of apoptosis induced by ceramide accumulation, which is associated with metabolic dynamics. Interestingly, apoptotic cells were not merely a byproduct of adipogenesis but rather promoted the release of lipid components to facilitate adipogenesis. Mechanistically, ceramide accumulation stemming from hydrolysis and the de novo pathway during early adipogenesis is regulated by Sirt1 upon epigenetic alterations of constitutive Histone H3K4 methylation and H3K9 acetylation. INTERPRETATION: The metabolic footprint during adipocyte commitment highlights that apoptosis induced by ceramide is essential for adipogenesis, which is reversed by suppression of Sirt1. Therefore, Sirt1 may constitute a target to treat obesity or other ceramide-associated metabolic syndromes. FUNDING: This project was supported by grants from the University of Macau (SRG2015-00008-FHS, MYRG2016-00054-FHS and MYRG2017-00096-FHS to RHW; CPG2019-00019-FHS to CXD) and from the National Natural Science Foundation of China (81672603 and 81401978) to QC. Elsevier 2020-01-02 /pmc/articles/PMC6940659/ /pubmed/31901865 http://dx.doi.org/10.1016/j.ebiom.2019.102605 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research paper
Hou, Weilong
Chen, Qiang
Wang, Haitao
Qiu, Pengxiang
Lyu, Xueying
Chen, Weiping
Chua, Melvin L.K.
Chinn, Y. Eugene
Deng, Chu-Xia
Wang, Ruihong
The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
title The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
title_full The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
title_fullStr The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
title_full_unstemmed The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
title_short The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
title_sort metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
topic Research paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940659/
https://www.ncbi.nlm.nih.gov/pubmed/31901865
http://dx.doi.org/10.1016/j.ebiom.2019.102605
work_keys_str_mv AT houweilong themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chenqiang themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT wanghaitao themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT qiupengxiang themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT lyuxueying themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chenweiping themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chuamelvinlk themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chinnyeugene themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT dengchuxia themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT wangruihong themetabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT houweilong metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chenqiang metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT wanghaitao metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT qiupengxiang metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT lyuxueying metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chenweiping metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chuamelvinlk metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT chinnyeugene metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT dengchuxia metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment
AT wangruihong metabolicfootprintduringadipocytecommitmenthighlightsceramidemodulationasanadequateapproachforobesitytreatment